Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

2.

Findings to date from the ASCUS-LSIL Triage Study (ALTS).

Schiffman M, Solomon D.

Arch Pathol Lab Med. 2003 Aug;127(8):946-9. Review.

PMID:
12873166
3.

Screening for cervical cancer: new alternatives and research.

Lörincz AT.

Salud Publica Mex. 2003;45 Suppl 3:S376-87. Review.

PMID:
14746031
4.
5.

Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.

Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M.

Cancer Cytopathol. 2013 Dec;121(12):675-87. doi: 10.1002/cncy.21325. Epub 2013 Jul 23. Review.

6.

Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.

Cox JT.

Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S15-25. Review.

PMID:
16729900
7.

[Role of high-risk human papillomavirus testing in the screening and management of cervical cancer precursors].

Jin Y, Pan LY.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):691-6. Review. Chinese.

8.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
9.

Management of cervical cytologic abnormalities.

Apgar BS, Brotzman G.

Am Fam Physician. 2004 Nov 15;70(10):1905-16. Review.

10.

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.

Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1157-64. Review.

12.

Human papillomavirus triage of patients with atypical squamous cells of undetermined significance on cervical Papanicolaou smear.

Kirby TO, Huh WK, Partridge EE.

Ann Acad Med Singapore. 2003 Sep;32(5):590-5; quiz 596. Review.

PMID:
14626785
13.

The role of human papillomavirus testing in cervical screening.

Cuschieri KS, Cubie HA.

J Clin Virol. 2005 Mar;32 Suppl 1:S34-42. Review.

PMID:
15753010
14.

[Ano-genital lesions due to human papillomavirus infection in women].

Heard I.

Med Mal Infect. 2005 May;35(5):302-5. Review. French.

PMID:
15876506
15.
16.

History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results.

Cox JT.

J Clin Virol. 2009 Jul;45 Suppl 1:S3-S12. doi: 10.1016/S1386-6532(09)70002-2. Review. Erratum in: J Clin Virol. 2010 Mar;47(3):299.

PMID:
19651367
18.

Cervical cancer screening from Pap smear to human papillomavirus DNA testing.

Jin XW, Xu H.

Compr Ther. 2001 Fall;27(3):202-8. Review.

PMID:
11569320
19.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

Arbyn M, Xu L, Verdoodt F, Cuzick J, Szarewski A, Belinson JL, Wentzensen N, Gage JC, Khan MJ.

Ann Intern Med. 2017 Jan 17;166(2):118-127. doi: 10.7326/M15-2735. Epub 2016 Nov 15. Review.

PMID:
27842420
20.

Tissue effects and host response. The key to the rational triage of cervical neoplasia.

Ferenczy A, Jenson AB.

Obstet Gynecol Clin North Am. 1996 Dec;23(4):759-82. Review.

PMID:
8989775

Supplemental Content

Support Center